These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7370174)

  • 21. Treatment of porphyria cutanea tarda.
    Malina L
    Br J Dermatol; 1987 Jan; 116(1):139-40. PubMed ID: 3814510
    [No Abstract]   [Full Text] [Related]  

  • 22. [Porphyria cutanea tarda and lupus erythematosus].
    Köstler E; Heinicke HJ; Schneider F; Riedel H; Hensel J
    Z Gesamte Inn Med; 1989 Sep; 44(17):527-9. PubMed ID: 2588723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda.
    Malina L; Chlumský J
    Acta Derm Venereol; 1981; 61(4):346-50. PubMed ID: 6173993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda].
    Drasch G; Eisenmenger W
    Z Rechtsmed; 1986; 97(4):285-93. PubMed ID: 3577436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desferrioxamine in the treatment of porphyria cutanea tarda: ineffectiveness of intramuscular administration.
    Muñoz JJ; Garcia-Cabezas J; Martinez-Verano J; Perez-Oteyza C; Enriquez de Salamanca R
    J Dermatol; 1990 May; 17(5):329-31. PubMed ID: 2380437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathology of the liver in porphyria cutanea tarda.
    Cortés JM; Oliva H; Paradinas FJ; Hernandez-Guío C
    Histopathology; 1980 Sep; 4(5):471-85. PubMed ID: 6253381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyria Cutanea tarda in Missouri.
    Anderson PC
    Mo Med; 1981 Jun; 78(6):299-302. PubMed ID: 7254176
    [No Abstract]   [Full Text] [Related]  

  • 32. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 34. Microscopic abnormalities in the liver of two patients with Porphyria variegata.
    Mascaro JM; Bruguera M; Herrero C; Lecha M; Muniesa AM
    J Cutan Pathol; 1985 Oct; 12(5):395-9. PubMed ID: 4056163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular basis of the action of chloroquine in porphyria cutanea tarda.
    Scholnick PL; Epstein J; Marver HS
    J Invest Dermatol; 1973 Oct; 61(4):226-32. PubMed ID: 4744026
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ultrastructural changes of hepatocytes in porphyria cutanea tarda. Preliminary note].
    Amerio PL; Garcovich A
    G Ital Dermatol Minerva Dermatol; 1970 Apr; 45(4):265-9. PubMed ID: 5537590
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chloroquine therapy in porphyria cutanea tarda].
    Snitker G
    Ugeskr Laeger; 1971 Aug; 133(33):1605-10. PubMed ID: 5099470
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis].
    Wolff C; Armas R; Krause P; Parraguez A; Ramón Soto J
    Rev Med Chil; 1996 Apr; 124(4):456-60. PubMed ID: 9110486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current therapeutic methods in porphyria cutanea tarda].
    Giannotti B
    G Ital Dermatol Venereol; 1984; 119(3):167-9. PubMed ID: 6746011
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanism of bullous formation in porphyria cutanea tarda. 1. Histopathological observation of bullae in 3 cases of porphyria cutanea tarda].
    Nagato N; Ohgami T; Murayama F; Honda T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1987 Mar; 97(4):471-7. PubMed ID: 3613213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.